Delayed response assessment with FDG-PET-CT following (chemo)radiotherapy for locally advanced head and neck squamous cell carcinoma

Clinical Radiology

Volumn 67, Issue 10, 2012, Pages 966-975

  Prestwich, R J D ^a   Subesinghe, M ^a   Gilbert, A ^a   Chowdhury, F U ^a   Sen M ^a   Scarsbrook, A F ^a  

^a St James's Institute of Oncology   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CISPLATIN; DOCETAXEL; FLUORODEOXYGLUCOSE F 18; FLUOROURACIL;

ADULT; ADVANCED CANCER; AGED; AREA UNDER THE CURVE; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER LOCALIZATION; CANCER PATIENT; CHEMORADIOTHERAPY; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL OBSERVATION; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE FREE SURVIVAL; DISEASE SEVERITY; DISTANT METASTASIS; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; IMAGE QUALITY; INTENSITY MODULATED RADIATION THERAPY; LYMPH NODE METASTASIS; MALE; METABOLISM; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PRIMARY TUMOR; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; TREATMENT DURATION; TREATMENT RESPONSE;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY; DELAYED DIAGNOSIS; FEMALE; FLUORODEOXYGLUCOSE F18; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; PROGNOSIS; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

EID: 84865750920     PISSN: 00099260     EISSN: 1365229X     Source Type: Journal    
DOI: 10.1016/j.crad.2012.02.016     Document Type: Article

References (30)

1. T.Y. Seiwert, and E.E. Cohen State-of-the-art management of locally advanced head and neck cancer Br J Cancer 92 2005 1341 1348
2. D.J. Adelstein, Y. Li, and G.L. Adams An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer J Clin Oncol 21 2003 92 98
3. A.A. Forastiere, H. Goepfert, and M. Maor Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer N Engl J Med 349 2003 2091 2098
4. A. Ferlito, J. Corry, and C.E. Silver Planned neck dissection for patients with complete response to chemoradiotherapy: a concept approaching obsolescence Head Neck 32 2010 253 261
5. D.M. Brizel, R.G. Prosnitz, and S. Hunter Necessity for adjuvant neck dissection in setting of concurrent chemoradiation for advanced head-and-neck cancer Int J Radiat Oncol Biol Phys. 58 2004 1418 1423
6. K.M. Stenson, D.J. Haraf, and H. Pelzer The role of cervical lymphadenectomy after aggressive concomitant chemoradiotherapy: the feasibility of selective neck dissection Arch Otolaryngol Head Neck Surg 126 2000 950 956
7. G.G. Grabenbauer, C. Rodel, and A. Ernst-Stecken Neck dissection following radiochemotherapy of advanced head and neck cancer - for selected cases only? Radiother Oncol 66 2003 57 63
8. E. Esteller, M.C. Vega, and M. Lopez Salvage surgery after locoregional failure in head and neck carcinoma patients treated with chemoradiotherapy Eur Arch Otorhinolaryngol 268 2011 295 301
9. M.T. Zundel, M.A. Michel, and C.J. Schultz Comparison of physical examination and fluorodeoxyglucose positron emission tomography/computed tomography 4-6 months after radiotherapy to assess residual head-and-neck cancer Int J Radiat Oncol Biol Phys. 81 2011 e825 e832
10. S.A. McHam, D.J. Adelstein, and L.A. Rybicki Who merits a neck dissection after definitive chemoradiotherapy for N2-N3 squamous cell head and neck cancer? Head Neck 25 2003 791 798
11. M.W. van den Brekel, H.V. Stel, and J.A. Castelijns Cervical lymph node metastasis: assessment of radiologic criteria Radiology 177 1990 379 384
12. S.V. Porceddu, D.I. Pryor, and E. Burmeister Results of a prospective study of positron emission tomography-directed management of residual nodal abnormalities in node-positive head and neck cancer after definitive radiotherapy with or without systemic therapy Head Neck 33 2011 1675 1682
13. D. Mak, J. Corry, and E. Lau Role of FDG-PET/CT in staging and follow-up of head and neck squamous cell carcinoma Q J Nucl Med Mol Imaging 55 2011 487 499
14. A. Paccagnella, M.G. Ghi, and L. Loreggian Concomitant chemoradiotherapy versus induction docetaxel, cisplatin and 5 fluorouracil (TPF) followed by concomitant chemoradiotherapy in locally advanced head and neck cancer: a phase II randomized study Ann Oncol 21 2010 1515 1522
15. T. Gupta, Z. Master, and S. Kannan Diagnostic performance of post-treatment FDG PET or FDG PET/CT imaging in head and neck cancer: a systematic review and meta-analysis Eur J Nucl Med Mol Imaging 38 2011 2083 2095
16. R.J. Prestwich, K. Kancherla, and D.C. Oksuz A single centre experience with sequential and concomitant chemoradiotherapy in locally advanced stage IV tonsillar cancer Radiat Oncol 5 2010 121
17. R.J. Prestwich, D.C. Oksuz, and K. Dyker Feasibility and efficacy of induction docetaxel, cisplatin, and 5-fluorouracil chemotherapy combined with cisplatin concurrent chemoradiotherapy for nonmetastatic stage iv head-and-neck squamous cell carcinomas Int J Radiat Oncol Biol Phys. 81 2011 e237 e243
18. J. Corry, L. Peters, and R. Fisher N2-N3 neck nodal control without planned neck dissection for clinical/radiologic complete responders-results of Trans Tasman Radiation Oncology Group Study 98.02 Head Neck 30 2008 737 742
19. P. Therasse, S.G. Arbuck, and E.A. Eisenhauer New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada J Natl Cancer Inst 92 2000 205 216
20. G. Ceulemans, M. Voordeckers, and A. Farrag Can 18-FDG-PET during radiotherapy replace post-therapy scanning for detection/demonstration of tumor response in head-and-neck cancer? Int J Radiat Oncol Biol Phys. 81 2011 938 942
21. S.C. Ong, H. Schoder, and N.Y. Lee Clinical utility of 18F-FDG PET/CT in assessing the neck after concurrent chemoradiotherapy for locoregional advanced head and neck cancer J Nucl Med 49 2008 532 540
22. R.E. Ware, J.P. Matthews, and R.J. Hicks Usefulness of fluorine-18 fluorodeoxyglucose positron emission tomography in patients with a residual structural abnormality after definitive treatment for squamous cell carcinoma of the head and neck Head Neck 26 2004 1008 1017
23. B.F. Branstetter 4th, T.M. Blodgett, and L.A. Zimmer Head and neck malignancy: is PET/CT more accurate than PET or CT alone? Radiology 235 2005 580 586
24. R. Syed, J.B. Bomanji, and N. Nagabhushan Impact of combined (18)F-FDG PET/CT in head and neck tumours Br J Cancer 92 2005 1046 1050
25. A. Gordin, M. Daitzchman, and I. Doweck Fluorodeoxyglucose-positron emission tomography/computed tomography imaging in patients with carcinoma of the larynx: diagnostic accuracy and impact on clinical management Laryngoscope 116 2006 273 278
26. H. Schoder, H.W. Yeung, and M. Gonen Head and neck cancer: clinical usefulness and accuracy of PET/CT image fusion Radiology 231 2004 65 72
27. M.G. Isles, C. McConkey, and H.M. Mehanna A systematic review and meta-analysis of the role of positron emission tomography in the follow up of head and neck squamous cell carcinoma following radiotherapy or chemoradiotherapy Clin Otolaryngol 33 2008 210 222
28. 18F- fluorodeoxyglucose positron emission tomography to evaluate cervical node metastases in patients with head and neck squamous cell carcinoma: a meta-analysis J Natl Cancer Inst 100 2008 712 720
29. K.M. Greven, D.W. Williams 3rd, and W.F. McGuirt Sr. Serial positron emission tomography scans following radiation therapy of patients with head and neck cancer Head Neck 23 2001 942 946
30. V.J. Lowe, J.H. Boyd, and F.R. Dunphy Surveillance for recurrent head and neck cancer using positron emission tomography J Clin Oncol 18 2000 651 658